Perioperative Durvalumab for Resectable NSCLC
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Perioperative Durvalumab for Resectable Non-Small-Cell Lung Cancer
N. Engl. J. Med 2023 Nov 02;389(18)1672-1684, JV Heymach, D Harpole, T Mitsudomi, JM Taube, G Galffy, M Hochmair, T Winder, R Zukov, G Garbaos, S Gao, H Kuroda, G Ostoros, TV Tran, J You, KY Lee, L Antonuzzo, Z Papai-Szekely, H Akamatsu, B Biswas, A Spira, J Crawford, HT Le, M Aperghis, GJ Doherty, H Mann, TM Fouad, M ReckFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.